{"anaemia": 8.2, "blood bilirubin increased": 3.48, "bronchospasm": 51.01, "disease progression": 2.36, "disease recurrence": 3.69, "eyelid oedema": 17.96, "eyelid ptosis": 17.91, "febrile neutropenia": 81.62, "haematotoxicity": 16.84, "haemoglobin decreased": 3.17, "infection": 2.48, "interstitial lung disease": 2.59, "leukopenia": 10.08, "madarosis": 48.41, "malignant neoplasm progression": 5.56, "mucosal inflammation": 9.72, "myelosuppression": 11.52, "neoplasm progression": 3.27, "neuroblastoma": 703.45, "neutropenia": 16.46, "neutrophil count decreased": 11.61, "pancytopenia": 16.22, "platelet count decreased": 6.5, "product use in unapproved indication": 9.35, "product use issue": 4.62, "red blood cell count decreased": 13.99, "respiratory failure": 2.66, "sepsis": 2.29, "small cell lung cancer": 78.61, "thrombocytopenia": 11.29, "treatment failure": 6.51, "white blood cell count decreased": 10.9}